Milk thistle is an oral seed-extract dietary supplement used mainly to support the liver. The strongest human signal is a modest, uncertain lowering of blood sugar in type 2 diabetes; cholesterol and liver-enzyme effects are inconsistent, and independent reviews found no reliable survival benefit in liver disease. Lifespan evidence is limited to worms and flies. Side effects are mostly mild digestive complaints. Product quality varies widely. (Full Review)
| Marker | Target | Why |
|---|---|---|
| ALT and AST | About 7–55 U/L (ALT) and 8–48 U/L (AST), laboratory-specific | Safety check; liver enzymes, a new rise from baseline signals a possible safety problem |
| HbA1c | No established target; track change from own baseline | Expected-change marker in type 2 diabetes |
| Fasting glucose | No established target; track change from own baseline | Expected-change marker; low values matter for people on diabetes medication |
| LDL cholesterol and triglycerides | No established target; track change from own baseline | Expected-change marker; effects are inconsistent across trials |
| INR | About 0.8–1.2 without anticoagulants | Safety check for warfarin users |
Cadence: Baseline before starting; about 2 to 4 weeks for liver enzymes and INR (if relevant); about 3 months for glucose, glycated hemoglobin and lipids; then every 6 to 12 months. Intervals reflect common practice; no guideline specifies them for milk thistle.